Frequently Asked Questions

It's the use of specific red and near-infrared wavelengths, delivered by LEDs, to stimulate biological activity in skin and the tissue beneath it. Formally it's called photobiomodulation, or low-level light therapy. What separates it from most other skin treatments is that it doesn't work through damage: ablative lasers and chemical peels create a controlled injury the skin then repairs, while red light therapy is non-ablative and non-thermal.

There is a real research base, and it is smaller and more mixed than most product pages suggest. Controlled trials have measured genuine changes in wrinkle volume and collagen markers, but the skin-rejuvenation literature is made up largely of small studies, some of them industry-linked. In 2025 a 21-member expert panel published the first evidence-based consensus on photobiomodulation's clinical use — skin rejuvenation was not among the indications it settled, and the panel called for ongoing research into aesthetic applications.

Roughly 633–660nm is where the collagen-endpoint evidence sits — the wrinkle and procollagen trials we cite all used that band. Around 830nm is near-infrared, which penetrates further and is used for deeper targets, which is why serious devices pair a visible red wavelength with an invisible near-infrared one. Worth knowing: no validated map of wavelength to specific effect exists. The American Academy of Dermatology notes that comparing studies is difficult because researchers use different devices, wavelengths, and protocols.

Irradiance is the light power delivered per square centimetre of skin, measured in mW/cm². It is the spec that determines whether a session delivers a meaningful dose at all. Most dermatologic studies fall around 20–60 mW/cm², with the broader published range spanning roughly 10–100. A mask that doesn't publish an irradiance figure gives you no way to place it against that literature.

On its own, no. Marketing tends to lead with session length because three minutes sounds better than twenty, but time means nothing without the power behind it. A short session on a low-output device can deliver less total energy than a longer session on a stronger one. Fluence — total energy per square centimetre — is commonly 4–18 J/cm² per session in published trials, though some used 66–126.

Less than the number suggests. What matters is even distribution across the treatment area, because gaps mean untreated skin. A raw LED count tells you nothing about whether coverage is uniform, so a high count clustered in the middle of a mask can treat less of your face than a lower count spread evenly to the temples, forehead edges, and jawline.

Two to three sessions per week. Both the 2007 split-face rejuvenation trial and the 2023 LED mask study were twice weekly. Higher-frequency schedules quoted on product pages are not what the trials tested.

Eight to twelve weeks is where trials measure meaningful change in wrinkles and firmness. That is the window the published literature works in, not a promise about any individual timeline — what you experience depends on the device, the protocol, and your skin.

No, and the difference is not cosmetic. LED masks are Class II devices regulated under 21 CFR 878.4810 and reach the market through 510(k) clearance, which demonstrates that a device is "substantially equivalent" to one already legally on the market. Premarket approval — what "FDA-approved" actually describes — requires, in the FDA's words, "valid scientific evidence that provides reasonable assurance that the device is safe and effective." Consumer LED masks do not take that pathway, so a mask advertised as FDA-approved is using the term incorrectly.

No. A 510(k) establishes that a device is substantially equivalent to something already being sold; it is not a finding that the device works. The American Academy of Dermatology puts it plainly — clearance means a device is considered safe, not necessarily effective.

The cleared over-the-counter consumer indications are full-face wrinkle reduction (FDA product code OHS) and mild-to-moderate acne (OLP). Separate codes cover temporary relief of minor muscle and joint pain with a temporary increase in local blood circulation (NHN), and promoting hair growth in men with androgenetic alopecia via laser combs (OAP). Wound healing — where the research narrative started — is not a cleared consumer indication.

The leading hypothesis is that red and near-infrared light is absorbed by cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain, increasing ATP production. Two secondary effects are proposed: nitric oxide release, associated in experimental studies with local vasodilation and increased blood flow, and a fibroblast response linked to increased type-1 procollagen and reduced MMP-1, the enzyme that breaks collagen down. That is a proposed chain, not a demonstrated one.

No. You will see the mitochondrial explanation stated as established fact on product pages, but the researchers who study it are more careful. Reviews describe the mechanism as not fully understood, and one of the field's most-cited authors co-published a 2022 paper titled "Mechanisms Beyond Cytochrome c Oxidase."

No. These devices emit no ultraviolet. They operate in the visible red and near-infrared bands, at the opposite end of the spectrum from UV, and the energy levels are low compared with lasers used for cutting or coagulating tissue.

Because most of it falls outside the range your eyes can see. The International Commission on Non-Ionizing Radiation Protection defines visible light as 380 to 780nm, and near-infrared emitters above roughly 780nm sit beyond that. A mask running near-infrared can be delivering its full output while appearing dark.

Deeper with longer wavelengths — that ordering is real. Any specific millimetre figure is not. Monte Carlo modelling of human skin put maximum penetration at about 5.4mm when penetration was defined as 1% of surface intensity, and about 0.37mm when the threshold was set at 13.5%. Same tissue, same model, a fifteen-fold difference in the answer depending only on where the cutoff is drawn. At 1mm deep, delivered energy is roughly 5% of the surface value for red and near-infrared alike.

Penetration depth increases with wavelength, so near-infrared reaches further into tissue than visible red. Beyond that ordering, what is better established is where each band has been studied: red is where most of the collagen-endpoint evidence sits, while near-infrared is used for deeper targets. Multi-wavelength devices cover both.

Amber, around 590nm, has been studied for erythema and pigmentation. It is the shortest and shallowest of the three bands commonly found in these devices. It is also worth knowing that in one of the main periocular wrinkle trials, 590nm was used as the comparison arm rather than as the treatment.

Three findings we could trace to a primary source. A randomized controlled trial of 137 women aged 40–65 reported roughly a 30% reduction in periocular wrinkle volume, using a split-face design of 660nm against 590nm over 10 sessions in four weeks — though a published response letter disputes that paper's reported dosimetry. A four-arm split-face trial of 76 participants recorded up to 36% wrinkle reduction in its best-performing arm. And in laboratory-grown human skin tissue, type-1 procollagen rose 31% while MMP-1 fell 18%. Three studies is not a large body of evidence.

No. That figure is the maximum recorded in the strongest arm of a four-arm trial — not an average across participants, and not what every arm achieved. Pulling the single best-case number out of trial data is one of the most common ways this category gets oversold.

One 2023 study is worth singling out for exactly that reason: a 630nm LED mask used twice weekly for three months documented reversal of photoaging signs. The device studied was a commercial product developed with its manufacturer, which is worth knowing when weighing the result.

The widest look at the field is a 2023 systematic review and meta-analysis that screened 554 articles and included 31. It found statistically significant pooled effects for red and blue LED in acne specifically. The same review noted inconsistency between studies on wound healing and atopic dermatitis outcomes.

No, and that gap is worth knowing about. The 21-member panel found photobiomodulation effective for peripheral neuropathy, androgenetic alopecia, wound ulcers of several etiologies, decubitus ulcers, pain from diabetic foot ulcers, and acute radiation dermatitis. Skin rejuvenation is not on that list — the panel called for ongoing research into aesthetic applications.

Largely because of how dose gets reported. Trials report power and energy in ways that cannot be compared across studies, and sometimes contradict themselves internally; a 2025 paper in PLOS One documents methodological and reporting problems across LED therapy research. Many rejuvenation studies are also small, uncontrolled, or industry-linked, with sample sizes in the dozens and self-reported outcomes.

It starts with an accident. In 1967 Endre Mester, at Semmelweis University in Budapest, found that shaved mice exposed to a low-powered ruby laser regrew hair faster than untreated controls; the work was published in 1968. In the 1990s, LEDs developed for NASA-funded plant lighting were used aboard the Space Shuttle, with medical research following at Marshall Space Flight Center. In 2003, a device from that lineage was cleared for temporary relief of minor muscle and joint pain.

Not as a research finding. NASA's own Spinoff publication records that scientists working under the plant lighting noticed abrasions on their hands appeared to heal faster than usual. That is an anecdote NASA published, not a study — and wound healing is not a cleared consumer indication for these devices.